Skip to content
AdminFeb 24, 2020< 1 min read

Drug pricing review group signs deal with Aetion

The Institute for Clinical and Economic Review (ICER) has partnered with Aetion to incorporate real-world patient health data into its drug pricing assessments. It aligns with national regulators like the FDA and NICE in considering the increased use of real-world data to evaluate treatment effectiveness.

Read More

RELATED ARTICLES